share_log

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

4：持股變動聲明-高管 Shah Vinay
美股SEC公告 ·  2024/11/19 05:05

Moomoo AI 已提取核心訊息

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah，致富金融(臨時代碼)的首席財務官，參與了2024年11月16日的一筆交易。公告中未披露該交易的具體細節，包括行動類型、狀態、股份數量、股份性質、交易價格以及交易後的持股情況。作爲公司的關鍵高管，Shah的任何交易活動都受到投資者的密切關注，並可能影響市場對該股票的看法。
Vinay Shah，致富金融(臨時代碼)的首席財務官，參與了2024年11月16日的一筆交易。公告中未披露該交易的具體細節，包括行動類型、狀態、股份數量、股份性質、交易價格以及交易後的持股情況。作爲公司的關鍵高管，Shah的任何交易活動都受到投資者的密切關注，並可能影響市場對該股票的看法。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Organovo Holdings
    ONVO
    -- 1.270
    Silexion Therapeutics
    SLXN
    -- 1.230
    LAVA Therapeutics
    LVTX
    -- 1.340
    Dominari Holdings
    DOMH
    -- 9.900
    GT Biopharma
    GTBP
    -- 2.4600
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    美聯儲暫停降息，你如何調整持倉？
    美聯儲宣布基準利率維持在4.25%—4.50%不變，符合市場預期。你會如何配置資產？ 展开
    FOMC新聞發佈會，2025年1月29日